Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA5 | P31644 | 3/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.40 |
| ▸ | GABRE | P78334 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.40 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.40 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.40 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
| ▸ | CPN1 | P15169 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2170647 | 0.84 | EPHX1 (0.37) | GABRA5GABRB2TSHRGABRA1GABRA4 | |
| Hydrochloric Acid SCHEMBL5058258 | 0.82 | EPHX1 (0.36) | GABRA5GABRB2TSHRGABRA1GABRA4 | |
| SCHEMBL9661170 | 0.74 | MEN1 (0.30) | TSHRMEN1KMT2A | |
| SCHEMBL6850315 | 0.72 | GABRA5 (0.36) | GABRA5GABRB2TSHRGABRA1GABRA4 | |
| SCHEMBL6854245 | 0.67 | EPHX1 (0.33) | GABRA5GABRB2TSHRGABRA1GABRA4 | |
| SCHEMBL5785736 | 0.67 | EPHX1 (0.33) | GABRA5GABRB2TSHRGABRA1GABRA4 | |
| SCHEMBL6628424 | 0.66 | APOBEC3A (0.34) | — | |
| SCHEMBL5744600 | 0.66 | ALDH1A1 (0.30) | — | |
| SCHEMBL18983618 | 0.66 | — | — | |
| SCHEMBL10425659 | 0.64 | MEN1 (0.33) | TSHREPHX1SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2880046-A1 | NOVEL CHARTREUSIN ANALOGUES | Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie (DE) | 2015-06-10 | — | — | EP | claimed |
| WO-2014019685-A1 | NOVEL CHARTREUSIN ANALOGUES | LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE (DE) | 2014-02-06 | — | — | WO | claimed |
| EP-2880046-A1 | NOVEL CHARTREUSIN ANALOGUES | Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie (DE) | 2015-06-10 | — | — | EP | disclosed |
| WO-2014019685-A1 | NOVEL CHARTREUSIN ANALOGUES | LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE (DE) | 2014-02-06 | — | — | WO | disclosed |
| EP-1483401-A1 | METHOD FOR SELECTING DRUG SENSITIVITY-DETERMINING FACTORS AND METHOD FOR PREDICTING DRUG SENSITIVITY USING THE SELECTED FACTORS | F.HOFFMANN-LA ROCHE AG (CH) | 2004-12-08 | — | — | EP | disclosed |
| WO-2003076660-A1 | METHOD FOR SELECTING DRUG SENSITIVITY-DETERMINING FACTORS AND METHOD FOR PREDICTING DRUG SENSITIVITY USING THE SELECTED FACTORS | F.HOFFMANN-LA ROCHE AG (CH) | 2003-09-18 | — | — | WO | disclosed |
| EP-1126851-A1 | PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPYLMETHYLCELLULOSE CAPSULES | PHARMACIA & UPJOHN S.p.A. (IT) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001010443-A1 | PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPYLMETHYLCELLULOSE CAPSULES | PHARMACIA & UPJOHN S.P.A. (IT) | 2001-02-15 | — | — | WO | disclosed |